US5824334A
(en)
*
|
1989-09-05 |
1998-10-20 |
University Of Utah Research Foundation |
Tobacco substitute
|
GB9212511D0
(en)
*
|
1992-06-12 |
1992-07-22 |
Cortecs Ltd |
Pharmaceutical compositions
|
DE4314976C1
(de)
*
|
1993-05-06 |
1994-10-06 |
Lohmann Therapie Syst Lts |
Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US5830853A
(en)
*
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
WO1995003771A1
(en)
*
|
1993-08-03 |
1995-02-09 |
Pacific Rim Productions Pty. Ltd. |
Treatment of oral ailments
|
US5679714A
(en)
*
|
1995-06-07 |
1997-10-21 |
Weg; Stuart L. |
Administration of ketamine for detoxification and treatment of tobacco addiction
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
WO1996000072A1
(en)
*
|
1994-06-23 |
1996-01-04 |
The Procter & Gamble Company |
Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
|
US5705183A
(en)
*
|
1994-11-16 |
1998-01-06 |
Phillips Company |
Cotton candy coated medication and a method for making and administering the same
|
US6524557B1
(en)
*
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
PL321094A1
(en)
*
|
1994-12-22 |
1997-11-24 |
Astra Ab |
Parathyroid hormone (pth) containing preparation administered by inhalation
|
BR9510510A
(pt)
|
1994-12-22 |
1998-07-07 |
Astra Ab |
Formulação em aerossol farmacêutica uso da mesma e processos para fabricação da mesma para tratamento de um paciente carente de terapia
|
DE69629108T2
(de)
*
|
1995-02-24 |
2004-04-22 |
Weg, Stuart L. |
Anwendung von ketamin zur entgiftung
|
WO1996029986A1
(en)
*
|
1995-03-29 |
1996-10-03 |
The Procter & Gamble Company |
Antitussive microcapsules
|
SE9601421D0
(sv)
*
|
1996-04-12 |
1996-04-12 |
Astra Ab |
New composition
|
US5726154A
(en)
*
|
1996-06-28 |
1998-03-10 |
University Of Utah Research Foundation |
Stabilization and oral delivery of calcitonin
|
JP2000505090A
(ja)
*
|
1996-07-11 |
2000-04-25 |
ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ |
インドール選択的セロトニンアゴニストを含む包接錯体
|
US6248789B1
(en)
|
1996-08-29 |
2001-06-19 |
Stuart L. Weg |
Administration of ketamine to manage pain and to reduce drug dependency
|
DE19645044A1
(de)
*
|
1996-10-31 |
1998-05-07 |
Falk Pharma Gmbh |
Verwendung von Ursodeoxycholsäure zur topischen Behandlung von Entzündungserkrankungen der Schleimhäute
|
WO1998027968A1
(en)
*
|
1996-12-20 |
1998-07-02 |
Nimni Marcel E |
Novel topical formulation of anti-inflammatory drugs for the treatment of localized pain
|
US5762494A
(en)
*
|
1997-03-24 |
1998-06-09 |
Archambault; Gregory A. |
Applicator device and method
|
US20040023948A1
(en)
*
|
1997-03-24 |
2004-02-05 |
Green Richard David |
Fast-dispersing dosage form containing 5-HT1 agonists
|
GB9706089D0
(en)
*
|
1997-03-24 |
1997-05-14 |
Scherer Ltd R P |
Pharmaceutical composition
|
US6096328A
(en)
*
|
1997-06-06 |
2000-08-01 |
The Procter & Gamble Company |
Delivery system for an oral care substance using a strip of material having low flexural stiffness
|
US20020018754A1
(en)
*
|
1999-03-15 |
2002-02-14 |
Paul Albert Sagel |
Shapes for tooth whitening strips
|
US6197331B1
(en)
|
1997-07-24 |
2001-03-06 |
Perio Products Ltd. |
Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
|
GB9717770D0
(en)
*
|
1997-08-21 |
1997-10-29 |
Scherer Ltd R P |
Pharmaceutical composition
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
WO1999034751A1
(en)
*
|
1998-01-06 |
1999-07-15 |
Sceusa Nicholas A |
A drug dosage form based on the teorell-meyer gradient
|
US20020010197A1
(en)
*
|
1998-01-13 |
2002-01-24 |
John Dixon |
Pharmaceutical compositions comprising a compound having dopamine (d2) receptor agonist activity and a compound (b) having beta2-adrenoreceptor agonist activity
|
US7022683B1
(en)
*
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
IL141095A0
(en)
*
|
1998-08-19 |
2002-02-10 |
Rtp Pharma Inc |
Injectable aqueous dispersions of propofol
|
US20020098264A1
(en)
*
|
1998-11-27 |
2002-07-25 |
Cherukuri Subraman R. |
Medicated chewing gum delivery system for nicotine
|
US6344222B1
(en)
|
1998-09-03 |
2002-02-05 |
Jsr Llc |
Medicated chewing gum delivery system for nicotine
|
US6358060B2
(en)
|
1998-09-03 |
2002-03-19 |
Jsr Llc |
Two-stage transmucosal medicine delivery system for symptom relief
|
SE9803240D0
(sv)
*
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
A pharmaceutical composition having a rapid action
|
US6884792B2
(en)
*
|
1999-01-08 |
2005-04-26 |
Marvin B. Bacaner |
Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions
|
MXPA01007024A
(es)
|
1999-01-08 |
2002-03-27 |
B Bacaner Marvin |
Composiciones y equipos novedosos de bretilio y su uso en la prevencion y el tratamiento de condiciones cardiovasculares.
|
AU2879100A
(en)
*
|
1999-02-12 |
2000-08-29 |
Miles A. Libbey Iii |
Formulation and system for intra-oral delivery of pharmaceutical agents
|
AU768471B2
(en)
|
1999-07-02 |
2003-12-11 |
Procter & Gamble Company, The |
Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip
|
JP2003507418A
(ja)
|
1999-08-24 |
2003-02-25 |
メディキュア インターナショナル インコーポレイテッド |
心血管疾患とその関連疾患の治療
|
AU2001261744A1
(en)
*
|
2000-05-19 |
2001-12-03 |
Npd Llc |
Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
|
AU2001281749A1
(en)
*
|
2000-08-14 |
2002-02-25 |
Fertin Pharma A/S |
Method for preparation of chewing gum with customer acceptable taste
|
US20020106407A1
(en)
*
|
2000-12-11 |
2002-08-08 |
Dennis Coleman |
Method and apparatus for treating breakthrough pain
|
US20020160043A1
(en)
*
|
2001-02-27 |
2002-10-31 |
Dennis Coleman |
Compositions and method of manufacture for oral dissolvable dosage forms
|
US6777000B2
(en)
*
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
JP2004537338A
(ja)
*
|
2001-03-02 |
2004-12-16 |
ユーロ−セルティーク,エス.エイ. |
個別の投与剤形を調合するための方法と装置
|
WO2002072102A1
(en)
*
|
2001-03-05 |
2002-09-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Taste masked liquid pharmaceutical compositions
|
US20030198669A1
(en)
*
|
2001-07-05 |
2003-10-23 |
R.T. Alamo Ventures I, Llc |
Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
|
US20030017175A1
(en)
*
|
2001-07-05 |
2003-01-23 |
R.T. Alamo Ventures I, Inc. |
Sublingual administration of dihydroergotamine for the treatment of migraine
|
US6685951B2
(en)
|
2001-07-05 |
2004-02-03 |
R. T. Alamo Ventures I, Inc. |
Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
|
US20030153590A1
(en)
*
|
2001-08-14 |
2003-08-14 |
Oy Contral Pharma Ltd |
Method of treating alcoholism or alcohol abuse
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
US6949240B2
(en)
*
|
2002-05-23 |
2005-09-27 |
The Procter & Gamble Company |
Tooth whitening products
|
US8524200B2
(en)
|
2002-09-11 |
2013-09-03 |
The Procter & Gamble Company |
Tooth whitening products
|
US20050019277A1
(en)
*
|
2002-09-11 |
2005-01-27 |
The Procter & Gamble Company |
Tooth whitening products
|
WO2004024225A1
(en)
*
|
2002-09-16 |
2004-03-25 |
Zicam, Llc. |
System and method for delivering a composition to the nasal membrane
|
US9561182B2
(en)
*
|
2003-08-22 |
2017-02-07 |
Cure Pharmaceutical Corporation |
Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
|
US8999372B2
(en)
*
|
2002-11-14 |
2015-04-07 |
Cure Pharmaceutical Corporation |
Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
|
US20040131662A1
(en)
|
2003-11-12 |
2004-07-08 |
Davidson Robert S. |
Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
|
US20040191302A1
(en)
|
2003-03-28 |
2004-09-30 |
Davidson Robert S. |
Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
|
US20040115244A1
(en)
*
|
2002-12-17 |
2004-06-17 |
Holgate Eric Jamison |
Methods and compositions for nicotine replacement therapy
|
US20080213363A1
(en)
*
|
2003-01-23 |
2008-09-04 |
Singh Nikhilesh N |
Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
|
US20040253307A1
(en)
*
|
2003-02-04 |
2004-12-16 |
Brian Hague |
Sugar-free oral transmucosal solid dosage forms and uses thereof
|
US7648981B2
(en)
*
|
2003-02-28 |
2010-01-19 |
Ym Biosciences Inc. |
Opioid delivery system
|
US7648982B2
(en)
*
|
2003-02-28 |
2010-01-19 |
Ym Biosciences Inc. |
Opioid delivery system
|
US20040202717A1
(en)
*
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
US7306812B2
(en)
*
|
2003-05-09 |
2007-12-11 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7276246B2
(en)
*
|
2003-05-09 |
2007-10-02 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US20050036953A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of ammonium lactate
|
US20050042182A1
(en)
*
|
2003-08-13 |
2005-02-24 |
Moshe Arkin |
Topical compositions of urea
|
US20050037040A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of urea and ammonium lactate
|
US20050042268A1
(en)
*
|
2003-07-16 |
2005-02-24 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
US20050020552A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
US20050025833A1
(en)
*
|
2003-07-16 |
2005-02-03 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
ES2654062T3
(es)
|
2003-07-24 |
2018-02-12 |
Glaxosmithkline Llc |
Películas de disolución oral
|
US20050042281A1
(en)
*
|
2003-08-21 |
2005-02-24 |
Singh Nikhilesh N. |
Compositions for delivering therapeutic agents across the oral mucosa
|
EP1691631A4
(de)
*
|
2003-11-07 |
2012-09-05 |
Us Smokeless Tobacco Co |
Tabakzusammensetzungen
|
US8627828B2
(en)
*
|
2003-11-07 |
2014-01-14 |
U.S. Smokeless Tobacco Company Llc |
Tobacco compositions
|
EP1715853A4
(de)
*
|
2004-02-17 |
2012-07-18 |
Transcept Pharmaceuticals Inc |
Zusammensetzungen zur abgabe von hypnotika im bereich der mundschleimhäute und verwendungsverfahren davon
|
US7161034B2
(en)
*
|
2004-04-20 |
2007-01-09 |
Dade Behring Inc. |
Lidocaine analogs and methods of making and using same
|
US20060127468A1
(en)
|
2004-05-19 |
2006-06-15 |
Kolodney Michael S |
Methods and related compositions for reduction of fat and skin tightening
|
US7754230B2
(en)
*
|
2004-05-19 |
2010-07-13 |
The Regents Of The University Of California |
Methods and related compositions for reduction of fat
|
PL2422789T3
(pl)
*
|
2004-05-19 |
2018-09-28 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Wstrzykiwalna kompozycja zawierająca deoksycholan sodu
|
EP1765300A2
(de)
*
|
2004-06-10 |
2007-03-28 |
Duramed Pharmaceuticals, Inc. |
Formulierungen von sumatriptan zur absorption durch biologische membranen, und herstellungs- und anwendungsverfahren
|
US20060004035A1
(en)
*
|
2004-06-25 |
2006-01-05 |
Cephalon, Inc. |
System for identification of a pharmaceutical product
|
US20060051413A1
(en)
*
|
2004-09-08 |
2006-03-09 |
Chow Sing S M |
Method of enhancing absorptions of transmucosal administration formulations
|
FR2883179B1
(fr)
|
2005-03-18 |
2009-04-17 |
Ethypharm Sa |
Comprime enrobe
|
US20060281783A1
(en)
*
|
2005-05-25 |
2006-12-14 |
Transoral Pharmaceuticals, Inc. |
Compositions and methods of treating middle-of-the night insomnia
|
US20070287740A1
(en)
*
|
2005-05-25 |
2007-12-13 |
Transcept Pharmaceuticals, Inc. |
Compositions and methods of treating middle-of-the night insomnia
|
US20070225322A1
(en)
*
|
2005-05-25 |
2007-09-27 |
Transoral Pharmaceuticals, Inc. |
Compositions and methods for treating middle-of-the night insomnia
|
US20100272769A1
(en)
*
|
2005-08-03 |
2010-10-28 |
Amcol International |
Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use
|
US20070031512A1
(en)
*
|
2005-08-03 |
2007-02-08 |
Amcol International Corporation |
Virus-interacting layered phyllosilicates and methods of inactivating viruses
|
US20080184618A1
(en)
*
|
2005-08-03 |
2008-08-07 |
Amcol International |
Virus-Interacting Layered Phyllosilicates and Methods of Use
|
US9289583B2
(en)
*
|
2006-01-06 |
2016-03-22 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
US8357114B2
(en)
|
2006-01-06 |
2013-01-22 |
Acelrx Pharmaceuticals, Inc. |
Drug dispensing device with flexible push rod
|
US8202535B2
(en)
*
|
2006-01-06 |
2012-06-19 |
Acelrx Pharmaceuticals, Inc. |
Small-volume oral transmucosal dosage forms
|
US8252329B2
(en)
|
2007-01-05 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US8535714B2
(en)
|
2006-01-06 |
2013-09-17 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8865743B2
(en)
|
2006-01-06 |
2014-10-21 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8753308B2
(en)
|
2006-01-06 |
2014-06-17 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
US9066847B2
(en)
*
|
2007-01-05 |
2015-06-30 |
Aceirx Pharmaceuticals, Inc. |
Storage and dispensing devices for administration of oral transmucosal dosage forms
|
US8252328B2
(en)
*
|
2006-01-06 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US20070260491A1
(en)
*
|
2006-05-08 |
2007-11-08 |
Pamela Palmer |
System for delivery and monitoring of administration of controlled substances
|
US20070299687A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Pamela Palmer |
Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
|
US8642016B2
(en)
|
2006-07-21 |
2014-02-04 |
Jsrnti, Llc |
Medicinal delivery system, and related methods
|
CN103550136B
(zh)
|
2006-07-21 |
2016-04-13 |
生物递送科学国际公司 |
吸收增强的经粘膜递送装置
|
US8158609B1
(en)
|
2006-11-02 |
2012-04-17 |
Novartis Ag |
Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
|
US20090214442A1
(en)
*
|
2006-12-01 |
2009-08-27 |
Cephalon, Inc. |
Oral Transmucosal Nicotine Dosage Form
|
US20080131508A1
(en)
*
|
2006-12-01 |
2008-06-05 |
Cephalon, Inc |
Oral transmucosal nicotine dosage form
|
WO2008091592A1
(en)
|
2007-01-22 |
2008-07-31 |
Targacept, Inc. |
Intranasal, buccal, and sublingual administration of metanicotine analogs
|
EP2431043A1
(de)
|
2007-05-23 |
2012-03-21 |
Amcol International Corporation |
Mit Cholesterin interagierende Phyllosilikate zur Unterdrückung der gastrointestinalen Cholesterinabsorption
|
CA2716835A1
(en)
|
2008-02-27 |
2009-09-03 |
Amcol International Corporation |
Methods of treating cardiovascular disorders associated with atherosclerosis
|
WO2009148442A1
(en)
|
2008-06-04 |
2009-12-10 |
Colgate-Palmolive Company |
Oral care implement with cavitation system
|
US8945592B2
(en)
|
2008-11-21 |
2015-02-03 |
Acelrx Pharmaceuticals, Inc. |
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
|
US8101593B2
(en)
|
2009-03-03 |
2012-01-24 |
Kythera Biopharmaceuticals, Inc. |
Formulations of deoxycholic acid and salts thereof
|
US11337962B2
(en)
|
2009-09-25 |
2022-05-24 |
Upsher-Smith Laboratories, Llc |
Formulations comprising triptan compounds
|
US9211282B2
(en)
*
|
2009-09-25 |
2015-12-15 |
Dr. Reddy's Laboratories Ltd. |
Formulations comprising triptan compounds
|
US8517729B2
(en)
|
2010-03-04 |
2013-08-27 |
The University of Western Ontario and Trudell Medical International |
Oral mouthpiece and method for the use thereof
|
CA2827643C
(en)
|
2011-02-18 |
2019-05-07 |
Kythera Biopharmaceuticals, Inc. |
Treatment of submental fat
|
US8653058B2
(en)
|
2011-04-05 |
2014-02-18 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
WO2013148883A1
(en)
*
|
2012-03-27 |
2013-10-03 |
University Of Utah Research Foundation |
Sample capture device and systems and methods of using same
|
EP2830548B1
(de)
|
2012-03-29 |
2019-09-18 |
Trudell Medical International |
Orale vorrichtung mit bolussimulator und verfahren zur verwendung davon
|
WO2013173716A2
(en)
|
2012-05-18 |
2013-11-21 |
University Of Utah Research Foundation |
Methods for diagnosing and monitoring eosinophilic esophagitis
|
RU2646502C2
(ru)
|
2012-10-17 |
2018-03-05 |
Дзе Проктер Энд Гэмбл Компани |
Полоска для доставки активного вещества для ухода за полостью рта и способы доставки активных веществ для ухода за полостью рта
|
EP2958594A4
(de)
*
|
2013-02-22 |
2017-03-01 |
Eastgate Pharmaceuticals Inc. |
Pharmazeutische zusammensetzung für die verbesserte transmukosale verabreichung von benzodiazepinen
|
US9744209B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9750785B2
(en)
|
2015-01-30 |
2017-09-05 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9937223B2
(en)
|
2015-01-30 |
2018-04-10 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9925233B2
(en)
|
2015-01-30 |
2018-03-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9687526B2
(en)
|
2015-01-30 |
2017-06-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9744239B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
BR112017024356A2
(pt)
*
|
2015-05-13 |
2018-07-31 |
Monopar Therapeutics Inc |
clonidina e/ou derivados de clonidina para uso na prevenção de lesão na pele resultante de radioterapia
|
USD838368S1
(en)
|
2015-12-09 |
2019-01-15 |
Trudell Medical International |
Oral device
|
WO2017098404A1
(en)
|
2015-12-09 |
2017-06-15 |
Trudell Medical International |
Oral device, assembly and method for the use thereof
|
US20170319832A1
(en)
*
|
2016-05-09 |
2017-11-09 |
Kelly Gardner |
Devices for hydrating patients
|
GB201709141D0
(en)
|
2017-06-08 |
2017-07-26 |
Klaria Pharma Holding Ab |
Pharmaceutical formulation
|
JP6671616B2
(ja)
*
|
2017-11-02 |
2020-03-25 |
コスメディ製薬株式会社 |
歯科用局所麻酔マイクロニードルアレイ
|
PL428534A1
(pl)
*
|
2019-01-10 |
2020-07-13 |
Biotts Spółka Akcyjna |
Nośnik farmaceutyczny dla substancji czynnych oraz kompozycja farmaceutyczna ją zawierająca
|
KR102458445B1
(ko)
*
|
2020-01-29 |
2022-10-24 |
박기원 |
반려동물용 다기능 미세 영양캡슐 제조방법 및 그 방법에 의해 제조된 반려동물용 미세 영양캡슐
|
US20230210159A1
(en)
*
|
2022-01-05 |
2023-07-06 |
Ava Jackson |
Flavor Delivery Device
|